retatrutide type 2 diabetes trial results Lilly's triple agonist delivers up to 71.2 lbs of weight loss The Effect of Retatrutide on

Notes: This visualization displays fee-for-service (FFS) retail pharmaceutical costs (billed on a pharmacy claim) paid by an insurance plan only

The ingredient is not only found in Wegovy but also Ozempic, another GLP-1 produced by the Danish manufacturer

The gallbladder needs to empty regularly to stay healthy

This study echoes that insurance barriers (and lack of coverage) suppress GLP-1 uptake: all patients had insurance, yet 40% of scripts were never filled ( [30] )

In February 2026, Novo Nordisk announced it will slash US list prices by up to 50% for Ozempic, Wegovy, and Rybelsus effective January 2027, bringing the list price to $675/month ( [74] )

Nevertheless, the majority of hypertensive human subjects treated with liraglutide do not exhibit an increase in circulating ANP [662]